$345.60
+7.38 (+2.18%)
At Close: Jun 04, 2026
AbbVie (ABBV) Beats on Q3 Earnings, Lags Sales, Narrows '22 View
04:47pm, Friday, 28'th Oct 2022 Zacks Investment Research
AbbVie's earnings (ABBV) beat estimates for third-quarter 2022, while sales miss the same. Shares drop in pre-market trading after it narrows down its full-year earnings guidance.
5 Stocks To Buy Now According To The Piotroski Score
02:47pm, Thursday, 27'th Oct 2022 Investing.comEarnings Preview: Amgen (AMGN) Q3 Earnings Expected to Decline
02:03pm, Thursday, 27'th Oct 2022 Zacks Investment Research
Amgen (AMGN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Will Gilead Sciences Stock Climb After Q3 Earnings?
12:05am, Thursday, 27'th Oct 2022 Zacks Investment Research
Big Pharma will close out this week's earnings reports, with Gilead Sciences (GILD) set to give its Q3 results on October 27. With GILD edging towards its 52-week highs, investors will want to see if
Investors Heavily Search Amgen Inc. (AMGN): Here is What You Need to Know
01:00pm, Tuesday, 25'th Oct 2022 Zacks Investment Research
Recently, Zacks.com users have been paying close attention to Amgen (AMGN). This makes it worthwhile to examine what the stock has in store.
Biosimilars Are Revolutionizing Healthcare: Is This Industry Leader a Buy?
10:50am, Tuesday, 25'th Oct 2022 The Motley Fool
Biosimilars are bringing down prescription drug costs without sacrificing quality.
Investors Heavily Search Amgen Inc. (AMGN): Here is What You Need to Know
10:32am, Tuesday, 25'th Oct 2022
Recently, Zacks.com users have been paying close attention to Amgen (AMGN). This makes it worthwhile to examine what the stock has in store.
The Near-Perfect Portfolio: Be Prepared To Weather The Storm
01:30pm, Saturday, 22'nd Oct 2022 Seeking Alpha
The market is going through a period of extraordinary uncertainty. The question is how to preserve wealth without compromising on upside. Click here to read the answer.
Amgen (AMGN) Gains But Lags Market: What You Should Know
09:50pm, Friday, 21'st Oct 2022 Zacks Investment Research
In the latest trading session, Amgen (AMGN) closed at $251.94, marking a +1.81% move from the previous day.
Amgen (AMGN) Stock Moves -0.3%: What You Should Know
10:00pm, Thursday, 20'th Oct 2022 Zacks Investment Research
In the latest trading session, Amgen (AMGN) closed at $247.45, marking a -0.3% move from the previous day.
Do Options Traders Know Something About Amgen (AMGN) Stock We Don't?
12:50pm, Thursday, 20'th Oct 2022 Zacks Investment Research
Investors need to pay close attention to Amgen (AMGN) stock based on the movements in the options market lately.
Is Amgen Stock a Buy Now?
12:45pm, Thursday, 20'th Oct 2022 The Motley Fool
A recent analyst upgrade has boosted the stock.
CRISPR Stocks: Will Concerns Over Risk Inhibit Gene-Editing Cures?
10:14am, Thursday, 20'th Oct 2022
Despite CRISPR stocks' enthusiasm, the risk of potential cures continues to cloud market projections for new gene-editing treatments moving through the pipeline toward FDA approval. The post CRISPR St
Is Amgen Stock a Buy Now?
08:45am, Thursday, 20'th Oct 2022
A recent analyst upgrade has boosted the stock.
2 Top Healthcare Stocks to Buy for the Long Haul
02:00pm, Tuesday, 18'th Oct 2022 The Motley Fool
These biotech companies have a long ramp of revenue growth ahead.
Sign In
Buy AMGN